Global Antifungal Agents Market

Antifungal Agents Market Size, Share, Growth Analysis, By Drug Type (Systemic Azoles & Polyenes, Topical Azoles & Polyenes), By Therapeutic Indication (Dermatophytosis, Candidiasis), By Type, By Route of Administration, By Distribution Channel, By Region - Industry Forecast 2026-2033

Report ID: SQMIG35J2113 | Region: Global | Published Date: January, 2025
Pages: 219 |Tables: 94 |Figures: 76

To request a free sample copy of this report, please complete the form below.

Our Clients

  • Schineder Electric
  • KSIA - Korea Semiconductor Industry Association
  • Hitachi Astemo Limited
  • Samsung Electronics
  • Halvo holdings
  • NTT corporation
  • AGC Inc
  • Siemens AG
  • Unilever
  • Merck Pharmaceuticals
  • Atlas Copco
  • Hologic - Medical Technology company
  • Novartis
  • Henkel
  • Reckitt
  • Schineder Electric
  • KSIA - Korea Semiconductor Industry Association
  • Hitachi Astemo Limited
  • Samsung Electronics
  • Halvo holdings
  • NTT corporation
  • AGC Inc
  • Siemens AG
  • Unilever
  • Merck Pharmaceuticals
  • Atlas Copco
  • Hologic - Medical Technology company
  • Novartis
  • Henkel
  • Reckitt

    • FAQs

    Global Antifungal Agents Market size was valued at USD 15.5 Billion in 2024 and is poised to grow from USD 16.12 Billion in 2025 to USD 22.06 Billion by 2033, growing at a CAGR of 4% during the forecast period (2026–2033).

    Antifungal agent manufacturers should invest heavily in R&D of novel agents and drugs that can be used for a wide variety of fungal infections. Antifungal agent companies can collaborate and partner with each other to fast track the development and launch of novel products going forward. 'Abbott (USA) ', 'Bayer AG (Germany) ', 'GSK plc (UK) ', 'Merck & Co., Inc. (USA) ', 'Cadila Pharmaceuticals (India) ', 'Glenmark Pharmaceuticals (India) ', 'SCYNEXIS, Inc. (USA) ', 'Astellas Pharma Inc. (Japan) ', 'Arcadia Consumer Healthcare (USA) ', 'Novartis AG (Switzerland) ', 'Pfizer Inc. (USA) ', 'Leadiant Biosciences, Inc. (USA) ', 'Sun Pharmaceutical Industries Ltd. (India) ', 'Viatris Inc. (USA) ', 'Sanofi (France) ', 'Gilead Sciences, Inc. (USA) ', 'Apotex Inc. (Canada) ', 'Aurobindo Pharma Limited (India) ', 'Cipla Inc. (India) ', 'Dr. Reddy's Laboratories Ltd. (India)'

    Widespread antibiotic resistance and growing incidence of infectious chronic diseases are key factors responsible for increasing fungal infections among patients, which in turn, is projected to boost antifungal agent demand outlook.

    Personalized Medicine: Antifungal agent vendors can collaborate and partner with personalized medicine companies to develop specialized treatments using antifungal agents for patients affected with different kinds of fungal infections. Antifungal agents companies can take advantage of advancements in different personalized medicine approaches to maximize their revenue generation.

    North America is estimated to account for a substantial share of the global antifungal agents market owing to rising cases of fungal infections in this region. of a developed healthcare infrastructure and growing investments in the R&D of novel antifungal drugs and medications are also contributing to the dominance of this segment over the coming years. Increasing cases of antifungal resistance in this region will also boost market growth going forward. The United States is forecasted to spearhead the demand for antifungal agents in the long run.

    Related Reports

    Fungicides Market
    Buy Now GET FREE SAMPLE
    Antiviral Drugs Market
    Buy Now GET FREE SAMPLE
    Animal Antibiotics and Antimicrobials Market
    Buy Now GET FREE SAMPLE
    Antimicrobial Coatings Market
    Buy Now GET FREE SAMPLE
    Yeast Ingredients Market
    Buy Now GET FREE SAMPLE
    Moringa Ingredients Market
    Buy Now GET FREE SAMPLE
    Antibiotics Market
    Buy Now GET FREE SAMPLE
    Herbal Medicine Market
    Buy Now GET FREE SAMPLE

    Feedback From Our Clients

    Global Antifungal Agents Market

    Report ID: SQMIG35J2113

    $5,300
    BUY NOW